Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amobarbital SCHEMBL1818832 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL43780 | 0.79 | LMNA (0.61) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL9869615 | 0.77 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL10911494 | 0.77 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL15419613 | 0.77 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL34587 | 0.77 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL30207759 | 0.77 | LMNA (0.59) | LMNAKDM4EALDH1A1CYP3A4GABRB3 | |
| Amobarbital SCHEMBL10335722 | 0.76 | CYP3A4 (0.33) | LMNACYP3A4 | |
| SCHEMBL17960486 | 0.76 | LMNA (0.34) | LMNA | |
| Amobarbital SCHEMBL28207058 | 0.76 | LMNA (0.57) | LMNAKDM4EALDH1A1CYP3A4GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109245-A1 | PREPARATION OF UNSATURATED POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2025-04-03 | — | — | US | disclosed |
| EP-4473036-A1 | PREPARATION OF UNSATURATED POLYESTERS | Eastman Chemical Company (US) | 2024-12-11 | — | — | EP | disclosed |
| CN-118613528-A | Preparation of unsaturated polyesters | 伊士曼化工公司 | 2024-09-06 | — | — | CN | disclosed |
| WO-2023147330-A1 | PREPARATION OF UNSATURATED POLYESTERS | EASTMAN CHEMICAL COMPANY (US) | 2023-08-03 | — | — | WO | disclosed |
| EP-3353228-B1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEM CO (US) | 2022-09-14 | — | — | EP | disclosed |
| EP-2912095-B1 | COPOLYESTERS CONTAINING NEOPENTYL GLYCOL AND 2,2,4,4-TETRAALKYL-1,3-CYCLOBUTANEDIOL | EASTMAN CHEM CO (US) | 2018-11-14 | — | — | EP | disclosed |
| EP-3353228-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | Eastman Chemical Company (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20180002482-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2018-01-04 | — | — | US | disclosed |
| WO-2017053379-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2-BIS(HYDROXYMETHYL)ALKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20170088665-A1 | POLYMERS CONTAINING CYCLOBUTANEDIOL AND 2,2 BIS(HYDROXYMETHYL) AlKYLCARBOXYLIC ACID | EASTMAN CHEMICAL COMPANY (US) | 2017-03-30 | — | — | US | disclosed |
| US-7838707-B2 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | EASTMAN CHEMICAL COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| US-7582804-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-09-01 | — | — | US | disclosed |
| US-7560600-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-07-14 | — | — | US | disclosed |
| US-7524994-B2 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2009-04-28 | — | — | US | disclosed |
| US-7521583-B2 | Process for the preparation of tetraalkylcyclobutane-1,3-diol in the presence of a cobalt-based catalyst | EASTMAN CHEMICAL COMPANY (US) | 2009-04-21 | — | — | US | disclosed |
| US-20080154069-A1 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | EASTMAN CHEMICAL COMPANY (US) | 2008-06-26 | — | — | US | disclosed |
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132737-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132738-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
| US-20080132739-A1 | PROCESS FOR THE PREPARATION OF TETRAALKYLCYCLOBUTANE-1,3-DIOL IN THE PRESENCE OF A COBALT-BASED CATALYST | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132739-A1 | PROCESS FOR THE PREPARATION OF TETRAALKYLCYCLOBUTANE-1,3-DIOL IN THE PRESENCE OF A COBALT-BASED CATALYST | TET1, TET3, HPD | LMNA 4417/4885ELANE 961/4885KDM4E 689/4885 |
| US-20080132738-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione in the presence of an zirconium-promoted nickel-based catalyst; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | ZRANB2, RCC1, TELO2 | LMNA 4321/4885ELANE 184/4885KDM4E 2176/4885 |
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | CA3, TELO2, CA1 | LMNA 4600/4885ELANE 736/4885KDM4E 1638/4885 |
| US-20080154069-A1 | for a specific cis:trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters; hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione from the pyrolysis of isobutyric anhydride and dimerization of the resulting dimethylketene | CA3, CA1, CA2 | LMNA 4357/4885ELANE 2547/4885KDM4E 1682/4885 |
| US-20080132737-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | TELO2, CA3, CA1 | LMNA 4675/4885ELANE 600/4885KDM4E 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.